7451 - 7500 of 9038 Results
Title
Year
- Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity2022RESTRICTEDTitle: Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 651End Page: 652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28929Citation Count: 7
- Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease2022RESTRICTEDTitle: Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 654End Page: 654Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28936Citation Count: 2
-
OPENTitle: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 291End Page: 301Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28952Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28952Citation Count: 23
- Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial2022RESTRICTEDTitle: Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1079End Page: 1087Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28953Citation Count: 17
- The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related Disorders2022RESTRICTEDTitle: The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 993End Page: 1003Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28958Citation Count: 14
- Physician‐Assisted Dying: Access and Utilization in Patients with Movement Disorders2022RESTRICTEDTitle: Physician‐Assisted Dying: Access and Utilization in Patients with Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 694End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28964Citation Count: 4
- Implementation and Outcomes of a Movement Disorder Society‐Sponsored Peer Reviewing Education and Mentoring Program2022RESTRICTEDTitle: Implementation and Outcomes of a Movement Disorder Society‐Sponsored Peer Reviewing Education and Mentoring ProgramJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1093End Page: 1097Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28978Citation Count: 3
- The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?2022RESTRICTEDTitle: The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 700End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28975Citation Count: 2
- Abstracts2022RESTRICTEDTitle: AbstractsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: S1Start Page: S1End Page: S36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29002Citation Count: 0
-
OPENTitle: Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates InflammationJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1405End Page: 1415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29025Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29025Citation Count: 77
- Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's Disease2022RESTRICTEDTitle: Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1557End Page: 1559Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29041Citation Count: 14
- Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health Implications2022OPENTitle: Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health ImplicationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 883End Page: 885Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29012Citation Count: 6
- An MDS Evidence‐Based Review on Treatments for Huntington's Disease2022RESTRICTEDTitle: An MDS Evidence‐Based Review on Treatments for Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1566End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29059Citation Count: 1
- TDP‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's Disease2022RESTRICTEDTitle: TDP‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1561End Page: 1563Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29048Citation Count: 36
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 20
- Reply to: “Diabetes and Neuroaxonal Damage in Parkinson's Disease”2022RESTRICTEDTitle: Reply to: “Diabetes and Neuroaxonal Damage in Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1569End Page: 1570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29064Citation Count: 0
- Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral Sclerosis2022RESTRICTEDTitle: Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral SclerosisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1756End Page: 1761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29079Citation Count: 5
- Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte Inclusions2022RESTRICTEDTitle: Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte InclusionsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1564End Page: 1565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29070Citation Count: 0
-
OPENTitle: Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential TremorJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1924End Page: 1929Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29130Citation Count: 15
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
- Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐Parkinsonism2022OPENTitle: Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2284End Page: 2289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29183Citation Count: 10
-
OPENTitle: Changes in Body Composition Before and After Parkinson's Disease DiagnosisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1617End Page: 1623Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28536Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10775470/pdf/nihms-1945637.pdfCitation Count: 23
- Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease2022RESTRICTEDTitle: Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1831End Page: 1840Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29157Citation Count: 39
-
OPENTitle: Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease SubtypesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2066End Page: 2074Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29172Best OA location URL: https://doi.org/10.1002/mds.29172Citation Count: 39
- Low Frequency of p.S510G in PIAS1 Challenges its Relevance for Modifying Repeat Expansion Disorders2022OPENTitle: Low Frequency of p.S510G in PIAS1 Challenges its Relevance for Modifying Repeat Expansion DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2168End Page: 2169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29191Citation Count: 1
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021OPENTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 49
-
OPENTitle: Replication of a Novel Parkinson's Locus in a European Ancestry PopulationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1689End Page: 1695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28546Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28546Citation Count: 19
- Parkinson's Kinesia Paradoxa Is Not a Paradox2021OPENTitle: Parkinson's Kinesia Paradoxa Is Not a ParadoxJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1115End Page: 1118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28550Citation Count: 34
- Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSA2021RESTRICTEDTitle: Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1466End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28571Citation Count: 6
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 25
- Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”2021RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0
- A New Approach to the Development of Disease‐Modifying Therapies for PD2021RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1927End Page: 1934Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28602Citation Count: 30
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28611Citation Count: 43
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28614Citation Count: 27
- Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein Pathology2021RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 6
-
OPENTitle: Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a SubgroupJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1468End Page: 1470Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28620Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28620Citation Count: 2
- Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning2021RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 89
- Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease2021RESTRICTEDTitle: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1964End Page: 1967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28630Citation Count: 6
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease2021OPENTitle: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2508End Page: 2518Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28639Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28639Citation Count: 104
- Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies2021RESTRICTEDTitle: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1731End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28637Citation Count: 8
- Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
OPENTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 6
- MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression2021RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
- Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”2021RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://pub.dzne.de/record/163488Citation Count: 29
- Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease2021RESTRICTEDTitle: Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2419End Page: 2425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28712Citation Count: 24
- Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs2021RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 80
- A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 Patients2021RESTRICTEDTitle: A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 PatientsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2446End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28718Citation Count: 8
- Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”2021RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0